Health knowledge made personal
Please enter a search word or phrase.
The search word cannot have more than 100 characteres.
Chronic Myeloid Leukemia - Articles
New Treatment for chronic myeloid leukemia
by
Katherine B.
Posted
Thu 28 May 2009 11:24pm
The FDA has approved Sprycel (dasatinib) for use in the treatment of adults in all phases of chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy including Gleevec.
Like Gleevec, Sprycel is very expensive. Gleevec can cost $35,000 dollars a year. The price of Sprycel, an oral medication, varies by dosage but the price
Read on »
The Faulty Gene Behind Chronic Myeloid Leukemia
by
CancerTeam ..
Posted
Sun 24 Aug 2008 1:49pm
.
ANNOUNCER: Nowell and Hungerford had discovered that patients with chronic myeloid leukemia-or CML-often had a chromosome that was missing a piece. It took more than a decade before... proved very effective against chronic myeloid leukemia. Trials showed imatinib worked well in returning a CML patient's elevated white blood counts to normal, what's called a good
Read on »
Monitoring Therapy in Chronic Myeloid Leukemia
by
CancerTeam ..
Posted
Sun 24 Aug 2008 1:49pm
ANNOUNCER: Treatment of chronic myeloid leukemia begins with bringing blood counts back to normal.
BRIAN DRUKER, MD: When a person is diagnosed with CML, they often..., PhD: Traditionally, with most of the leukemias, we don't start to consider that someone's been cured unless they've been free of their disease for at least five years, and CML
Read on »
Are chronic myeloproliferative disorders really leukemias?
by
pathologystudent
Posted
Wed 12 May 2010 8:01am
chronic myelogenous leukemia be placed into? I have been grouping it with the MPDs, but then I get confused when I start to compare it to acute myelogenous leukemia, which is just.... There are two big categories of leukemias: acute leukemias and chronic leukemias. The acute leukemias are divided into acute myeloid leukemia and acute lymphoblastic leukemia; the chronic
Read on »
Neulasta and neupogen for acute myeloid leukemia
by
Mark Levin
Posted
Fri 31 Jul 2009 11:41am
in acute leukemias. Whether administered before, during, or after chemotherapy for acute myeloid and acute lymphoblastic leukemias, these agents reduce the duration of neutropenia... in the intermediate risk group of patients with acute myeloid leukemia, but no overall survival benefit.G-CSF is usually well tolerated and medullary bone pain is the most frequently reported
Read on »